Hasty Briefsbeta

Bilingual

DLK, NMNAT2, and SARM1: Judge, Jury, and Executioner in Axon Degeneration - PubMed

4 hours ago
  • #therapeutic targets
  • #axon degeneration
  • #neurodegeneration
  • Axon degeneration is a regulated process central to neurodegenerative diseases.
  • DLK, NMNAT2, and SARM1 form a molecular axis for axonal self-destruction.
  • DLK initiates MAPK signaling to express prodegenerative genes upon stress.
  • NMNAT2 depletion post-injury leads to NMN accumulation, activating SARM1.
  • SARM1 is the central executioner of axon degeneration.
  • Targeting DLK, NMNAT2, and SARM1 offers therapeutic opportunities for neurodegenerative disorders.